London Daily

Focus on the big picture.
Tuesday, Sep 30, 2025

New Vaccines May Not Need Needles Or Cold Storage: WHO Chief Scientist

New Vaccines May Not Need Needles Or Cold Storage: WHO Chief Scientist

Six-to-eight new immunizations may complete clinical studies and undergo regulatory review by the end of the year, Soumya Swaminathan, the Geneva-based agency's chief scientist, said.

New Covid-19 vaccines, including ones that don't require needles and can be stored at room temperature, may be ready for use later this year or next year, the World Health Organization's top scientist said.

Six-to-eight new immunizations may complete clinical studies and undergo regulatory review by the end of the year, Soumya Swaminathan, the Geneva-based agency's chief scientist, said in an interview Saturday.

New vaccines will add to the 10 already shown to work within a year of Covid-19 being declared a pandemic. The world needs more immunizations, especially as the virus's continuous circulation spawns dangerous new variants and drugmakers struggle to meet orders. Only 122 countries have started immunizing people, according to data collected by Bloomberg.

"We're thrilled with the vaccines that we have," said Swaminathan, an Indian pediatrician best known for her research on tuberculosis and HIV. But "we can improve further," she said. "I think, well into 2022, we're going to see the emergence of improved vaccines."

The current crop of experimental vaccines use alternative technologies and delivery systems, and include more single-shot inoculations, and vaccines that are administered orally, via a nasal spray, and through the skin using a type of patch. These could bring immunizations that are better suited to specific groups, such as pregnant women, according to Swaminathan.

More than 80 candidate vaccines are being studied in people, though some are still in the early stages of testing and may not be successful. Companies with Covid-19 vaccines already in use have also begun testing updated versions designed to thwart variants of the coronavirus that have emerged in recent months.

Booster Shots


"We need to continue to support the research and development of more vaccine candidates, especially as the need for ongoing booster immunization of populations is still not very clear at this point," Swaminathan said. "So we need to be prepared for that in the future."

The WHO's strategic advisory group of experts on immunization is reviewing whether people who have been infected with SARS-CoV-2 need to have two doses of vaccine. Some research indicates that a natural infection works to prime the immune response to SARS-CoV-2, much as a first dose would, making a second injection unnecessary.

Giving only one dose of vaccine to Covid-19 survivors could free up more supplies, Swaminathan said, though it could present "practical and logistical challenges in many countries" if blood tests are needed to measure patients' antibody levels before deciding if a second jab is warranted.

The roll out of safe and effective vaccines is also raising questions about how to efficiently and ethically conduct clinical trials of experimental vaccines, she said. Placebos will be replaced with a "gold standard" vaccine in a so-called non-inferiority design when it's no longer ethical to use a placebo, Swaminathan said.

Global Trial


Meantime, one approach the WHO is exploring is to compare three or four candidate vaccines simultaneously with a placebo. A similar study design was used to test the efficacy of drug therapies for Covid-19, and may mean trial participants would have an 80% chance of receiving an experimental vaccine and only a 20% chance of getting placebo.

"We are in discussions now with several companies with vaccines in development to see if we could launch something like this on a global trial platform," Swaminathan said, adding that she's optimistic such a study may begin in the first half of 2021.

A global trial involving a wide pool of people and countries offers several advantages, she said. Testing vaccines in diverse ethnicities, age groups, and people with different medical conditions makes the results more generalizable, and when the epidemic wanes in some parts of the world it's often still active in others, she said.

Newsletter

Related Articles

0:00
0:00
Close
Trump Announces Intention to Impose 100 Percent Tariff on Foreign-Made Films
Altman Says GPT-5 Already Outpaces Him, Warns AI Could Automate 40% of Work
Singapore and Hong Kong Vie to Dominate Asia’s Rising Gold Trade
Trump Organization Teams with Saudi Developer on $1 Billion Trump Plaza in Jeddah
Manhattan Sees Surge in Office-to-Housing Conversions, Highest Since 2008
Switzerland and U.S. Issue Joint Assurance Against Currency Manipulation
Electronic Arts to Be Taken Private in Historic $55 Billion Buyout
Thomas Jacob Sanford Named as Suspect in Deadly Michigan Church Shooting and Arson
Russian Research Vessel 'Yantar' Tracked Mapping Europe’s Subsea Cables, Raising Security Alarms
New York Man Arrested After On-Air Confession to 2017 Parents’ Murders
U.S. Defense Chief Orders Sudden Summit of Hundreds of Generals and Admirals
Global Cruise Industry Posts Dramatic Comeback with 34.6 Million Passengers in 2024
Trump Claims FBI Planted 274 Agents at Capitol Riot, Citing Unverified Reports
India: Internet Suspended in Bareilly Amid Communal Clashes Between Muslims and Hindus
Supreme Court Extends Freeze on Nearly $5 Billion in U.S. Foreign Aid at Trump’s Request
Archaeologists Recover Statues and Temples from 2,000-Year-Old Sunken City off Alexandria
China Deploys 2,000 Workers to Spain to Build Major EV Battery Factory, Raising European Dependence
Speed Takes Over: How Drive-Through Coffee Chains Are Rewriting U.S. Coffee Culture
U.S. Demands Brussels Scrutinize Digital Rules to Prevent Bias Against American Tech
Ringo Starr Champions Enduring Beatles Legacy While Debuting Las Vegas Art Show
Private Equity’s Fundraising Surge Triggers Concern of European Market Shake-Out
Colombian President Petro Vows to Mobilize Volunteers for Gaza and Joins List of Fighters
FBI Removes Agents Who Kneeled at 2020 Protest, Citing Breach of Professional Conduct
Trump Alleges ‘Triple Sabotage’ at United Nations After Escalator and Teleprompter Failures
Shock in France: 5 Years in Prison for Former President Nicolas Sarkozy
Tokyo’s Jimbōchō Named World’s Coolest Neighbourhood for 2025
European Officials Fear Trump May Shift Blame for Ukraine War onto EU
BNP Paribas Abandons Ban on 'Controversial Weapons' Financing Amid Europe’s Defence Push
Typhoon Ragasa Leaves Trail of Destruction Across East Asia Before Making Landfall in China
The Personality Rights Challenge in India’s AI Era
Big Banks Rebuild in Hong Kong as Deal Volume Surges
Italy Considers Freezing Retirement Age at 67 to Avert Scheduled Hike
Italian City to Impose Tax on Visiting Dogs Starting in 2026
Arnault Denounces Proposed Wealth Tax as Threat to French Economy
Study Finds No Safe Level of Alcohol for Dementia Risk
Denmark Investigates Drone Incursion, Does Not Rule Out Russian Involvement
Lilly CEO Warns UK Is ‘Worst Country in Europe’ for Drug Prices, Pulls Back Investment
Nigel Farage Emerges as Central Force in British Politics with Reform UK Surge
Disney Reinstates ‘Jimmy Kimmel Live!’ after Six-Day Suspension over Charlie Kirk Comments
U.S. Prosecutors Move to Break Up Google’s Advertising Monopoly
Nvidia Pledges Up to $100 Billion Investment in OpenAI to Power Massive AI Data Center Build-Out
U.S. Signals ‘Large and Forceful’ Support for Argentina Amid Market Turmoil
Nvidia and Abu Dhabi’s TII Launch First AI-&-Robotics Lab in the Middle East
Vietnam Faces Up to $25 Billion Export Loss as U.S. Tariffs Bite
Europe Signals Stronger Support for Taiwan at Major Taipei Defence Show
Indonesia Court Upholds Military Law Amid Concerns Over Expanded Civilian Role
Larry Ellison, Michael Dell and Rupert Murdoch Join Trump-Backed Bid to Take Over TikTok
Trump and Musk Reunite Publicly for First Time Since Fallout at Kirk Memorial
Vietnam Closes 86 Million Untouched Bank Accounts Over Biometric ID Rules
Explosive Email Shows Sarah Ferguson Begged Forgiveness from Jeffrey Epstein After Taking His Money
×